Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
American Heart Journal
|
July 29, 2014
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial
Erik Kjøller, Jørgen Hilden, Per Winkel, et al.
European Heart Journal
|
March 10, 2009
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
Jens Kastrup, Julia S Johansen, Per Winkel, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
November 27, 2010
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial
Marina J Harutyunyan, Anders B Mathiasen, Per Winkel, et al.
Diagnostic Microbiology and Infectious Disease
|
March 16, 2010
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial
Jørgen Hilden, Inga Lind, Hans Jørn Kolmos, et al.
BMJ (Clinical Research Ed.)
|
December 13, 2005
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
Christian M Jespersen, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Cardiovascular Pharmacology
|
November 19, 2009
Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease
Gorm B Jensen, Jørgen Hilden, Bodil Als-Nielsen, et al.
Cardiology
|
May 3, 2008
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease
Christian Gluud, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Virological Methods
|
May 24, 2017
Inactivation of West Nile virus in serum with heat, ionic detergent, and reducing agent for proteomic applications
Louis A Altamura, Lisa H Cazares, Susan R Coyne, et al.
Science Immunology
|
March 27, 2021
A tumor-specific mechanism of T<sub>reg</sub> enrichment mediated by the integrin αvβ8
Robert I Seed, Kenji Kobayashi, Saburo Ito, et al.
Science Translational Medicine
|
March 23, 2018
An OX40/OX40L interaction directs successful immunity to hepatitis B virus
Jean Publicover, Anuj Gaggar, Jillian M Jespersen, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
American Heart Journal
|
July 29, 2014
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial
Erik Kjøller, Jørgen Hilden, Per Winkel, et al.
European Heart Journal
|
March 10, 2009
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
Jens Kastrup, Julia S Johansen, Per Winkel, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
November 27, 2010
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial
Marina J Harutyunyan, Anders B Mathiasen, Per Winkel, et al.
Diagnostic Microbiology and Infectious Disease
|
March 16, 2010
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial
Jørgen Hilden, Inga Lind, Hans Jørn Kolmos, et al.
BMJ (Clinical Research Ed.)
|
December 13, 2005
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
Christian M Jespersen, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Cardiovascular Pharmacology
|
November 19, 2009
Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease
Gorm B Jensen, Jørgen Hilden, Bodil Als-Nielsen, et al.
Cardiology
|
May 3, 2008
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease
Christian Gluud, Bodil Als-Nielsen, Morten Damgaard, et al.
Journal of Virological Methods
|
May 24, 2017
Inactivation of West Nile virus in serum with heat, ionic detergent, and reducing agent for proteomic applications
Louis A Altamura, Lisa H Cazares, Susan R Coyne, et al.
Science Immunology
|
March 27, 2021
A tumor-specific mechanism of T<sub>reg</sub> enrichment mediated by the integrin αvβ8
Robert I Seed, Kenji Kobayashi, Saburo Ito, et al.
Science Translational Medicine
|
March 23, 2018
An OX40/OX40L interaction directs successful immunity to hepatitis B virus
Jean Publicover, Anuj Gaggar, Jillian M Jespersen, et al.
Page
of 12